Globant S.A. (GLOB) shares dropped approximately 8.00% in the latest session. The decline was driven primarily by investor concerns around slowing growth in IT services demand.

Acadian Asset Management Inc. (AAMI) shares fell approximately 11.00% in the latest session. The sharp decline appears tied to earnings-related concerns and weaker-than-expected asset flows

SLBT shares declined approximately 19.6% over the past 30 days, closing at $6.28 on June 17, 2026, compared to $7.81 on May 18, 2026. The stock has experienced extreme volatility following its June 15 Nasdaq debut after completing a SPAC merger with Horizon Space Acquisition II Corp.

NovoCure shares are down approximately 16% in premarket trading on June 18, 2026, with the stock quoted near $14.95 against a prior regular-session close of $17.85. The primary catalyst is the announcement that the company's Phase 3 TRIDENT trial in newly diagnosed glioblastoma failed to meet its primary endpoint of demonstrating a statistically significant improvement in overall survival.

Legend Biotech shares are down approximately 11% in premarket trading on June 18, 2026, after closing the prior session at $33.52 on June 17. The primary catalyst is the company's announced pricing of a $226 million underwritten public offering of 7.7 million American Depositary Shares (ADSs) at $29.35 per ADS — a significant discount to the prior closing price.

Accenture shares are down approximately 16.72% in premarket trading on June 18, 2026, with the stock quoted around $130.09 following the prior regular-session close of $156.21. The primary catalyst is a disappointing Q3 FY2026 revenue miss combined with a meaningful cut to full-year revenue guidance, spooking investors already sensitive to IT spending trends.

AVGO shares declined approximately 6.6% over the last 30 days, closing at $392.91 on June 17, 2026, as post-earnings selling pressure offset robust AI demand signals. Q2 FY2026 results delivered record revenue of $22.19 billion (up 48% year-over-year) and AI semiconductor revenue of $10.8 billion (up 143% YoY), yet the stock sold off sharply when full-year AI guidance was reiterated rather than raised.

Accenture is scheduled to report third-quarter fiscal 2026 results before market open on June 18, 2026. Analysts expect earnings per share of approximately $3.71, up about 6% from the year-ago quarter.

Kroger is scheduled to report first quarter 2026 results on June 18, 2026. Analysts project earnings per share of approximately $1.59.

Analysts expect Methode Electronics to report a fiscal fourth-quarter loss amid ongoing industry challenges in automotive and industrial sectors. Consensus estimates point to revenue near prior-year levels with EPS around -$0.19.

National Vision Holdings shares tumbled approximately 7.29% on Wednesday, sliding from a prior close of $17.57 to an intraday low near $16.29. The primary pressure stemmed from persistent post-earnings weakness and investor unease over second-quarter comparable sales tracking in the low-single-digit range following an e-commerce platform disruption.

CarMax (KMX) shares plunged approximately 10.25% on Wednesday, closing near $46.77 after a prior session close of $52.11. The sell-off came despite a strong headline earnings beat — adjusted EPS of $1.31 trounced the $0.95 consensus, and revenue of $8.01 billion exceeded the $7.4 billion estimate.

GENI shares tumbled approximately 11.14% in after-hours trading Wednesday, extending a sharp intraday sell-off from the prior close of $6.87 to a post-market level near $6.11. The primary catalyst was aggressive profit-taking after a blistering 35% rally that carried the stock from roughly $5.30 in late May to above $7.20 by mid-June.

ROOT shares tumbled 13.54% in extended-hours trading on Tuesday, dropping to $49.43 from a prior regular-session close of $57.17. The decline occurred on extremely thin after-hours volume of just 200 shares, amplifying the magnitude of the move.

Regencell Bioscience Holdings shares tumbled approximately 11.54% in after-hours trading on June 17, 2026, extending a multi-day selloff. The primary catalyst is an intensifying legal storm — multiple securities class action lawsuits and a U.

RGNX shares surged 22.80% to close at $8.51 on June 17, 2026, up from the prior session's close of $6.93, marking the stock's strongest single-day gain since the May 14 selloff. Primary catalyst: Anticipation of the imminent $100 million AbbVie milestone payment , triggered upon first patient dosing in the Phase IIb/III NAAVIGATE diabetic retinopathy study, which management guided would occur in Q2 2026 — a quarter that ends in just 13 days.

CME Group shares dropped 4.90% in trading on June 17, 2026, falling from a prior close of $261.60 to $248.78. The primary catalyst was the announcement that longtime Chairman and CEO Terry Duffy will step down as Chief Executive Officer in March 2027, transitioning to Executive Chairman.

SOXL is trading up approximately 8.42% in Wednesday's premarket session, with units changing hands near $245.23 versus a prior closing price of $226.19. The primary driver is a broad semiconductor sector recovery rally, as AI-driven demand optimism continues to pull chip stocks higher following the sharp sector-wide sell-off triggered by the stronger-than-expected May jobs report in early June.